The Recall Desk

FDA (Drugs) recall action 83074

RXQ Compounding LLC recalled 86 products on 2019-08-14

The FDA (Drugs) publishes a recall like this one as 86 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 86 pages.

Products
86
Announced
2019-08-14
Critical
0
Units

Why these products were recalled

Lack of Assurance of Sterility

Crystallization

The agency’s own wording, quoted from the enforcement report.

51–75 of 86

  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls SOD-PHOS Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling SOD-PHOS injection vials because the product lacks assurance of sterility. The recall covers all lots within their expiry dates.

    Product
    SOD-PHOS (PHOS 3MMOL/ML-SOD 4MEQ/ML) PFV INJ SOLN, 10 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0905-10
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Travasol 10% Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Travasol 10% Injection Solution because the product lacks assurance of sterility.

    Product
    TRAVASOL 10% (AMINO ACID) INJECTION SOLUTION, 50 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0151-50
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Hydroxocobalamin Injections Due to Sterility Concerns

    RXQ Compounding LLC is recalling Hydroxocobalamin 1000 mcg/mL injections because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    HYDROXOCOBALAMIN 1000 MCG/ML (PFV), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0949-10
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Buffered Lidocaine HCL 1% Injection Solution

    RXQ Compounding LLC is recalling Buffered Lidocaine HCL 1% Injection Solution due to a lack of assurance of sterility.

    Product
    BUFFERED LIDOCAINE HCL 1% INJECTION SOLUTION (PF), 10ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0139-10
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Sterile Water for Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Sterile Water for Injection USP vials because the product lacks assurance of sterility.

    Product
    STERILE WATER FOR INJECTION USP, [10, 30, or 50 ML] per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 10 ML vial: 70731-0188-10; NDC 30 ML vial: 70731-0188-30; NDC 50 ML vial: 70731-0188-50
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls DMPS Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Dimercapto-Propanesulfonic 5% (DMPS) injection solution because the product lacks assurance of sterility.

    Product
    DIMERCAPTO-PROPANESULFONIC 5% (DMPS)( (PFV) INJ SOL, 5 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0904-05
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Morphine Syringes Due to Sterility Concerns

    RXQ Compounding LLC is recalling Morphine 1mg/mL in NaCl 0.9% 55mL syringes because the company cannot ensure the product is sterile.

    Product
    MORPHINE 1MG/ML IN NACL 0.9% 55ML SYR (C-II), 55 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0138-89
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Pyridoxine Vials Due to Sterility Concerns

    RXQ Compounding LLC is recalling Pyridoxine (PFV) 100mg/mL vials because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    PYRIDOXINE (PFV) 100MG/ML, 30ML PER VIAL. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0955-30
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Magnesium Chloride Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Magnesium Chloride Hexahydrate 20% Injection Solution because the product lacks assurance of sterility.

    Product
    MAGNESIUM CHLORIDE HEXAHYDRATE (MDV) 20% INJ SOLN, 50 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0977-50
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls TURBO DROPS Ophthalmic Solution Due to Sterility Concerns

    RXQ Compounding LLC is recalling TURBO DROPS ophthalmic solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    TURBO DROPS (PHEN 10% / CYCLO 1%/ TROP 1%/ KETO 0.5%) OPHTH SOLN, 5 ML per dropper bottle, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0206-05
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Hydroxocobalamin Injections Due to Sterility Concerns

    RXQ Compounding LLC is recalling Hydroxocobalamin 1000 mcg/mL injections because the product lacks assurance of sterility.

    Product
    HYDROXOCOBALAMIN 1000 MCG/ML (MDV), 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0926-30
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Diazepam Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling diazePAM 5 MG/ML Injection Solution because the product lacks assurance of sterility.

    Product
    diazePAM 5 MG/ML INJECTION SOLUTION (C-IV) SYR, 2 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0929-02
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Zinc Sulfate Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Zinc Sulfate 1mg/mL Injection Solution because the product lacks assurance of sterility.

    Product
    ZINC SULFATE 1MG/ML INJECTION SOLUTION (PFV), 10ML per VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0963-10
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Prednisolone and Moxifloxacin Ophthalmic Solution

    RXQ Compounding LLC is recalling Prednisolone 1% and Moxifloxacin 0.5% ophthalmic solution due to a lack of assurance of sterility.

    Product
    PREDNISOLONE 1%, MOXIFLOXACIN 0.5% OPHTH SOL, 5ML per dropper bottle, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0109-05
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Dexpantenol Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Dexpantenol 250mg/mL Injection Solution because the product lacks assurance of sterility.

    Product
    DEXPANTHENOL 250MG/ML (MDV) INJECTION SOLN, 30ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0932-30
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Phenylephrine Syringes Due to Sterility Concerns

    RXQ Compounding LLC is recalling Phenylephrine HCL 100 mcg/mL syringes because the agency could not ensure the product was sterile.

    Product
    PHENYLEPHRINE HCL 100 MCG/ML IN NACL 0.9% SYR, 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0136-10
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Neostigmine Methyl Sulfate Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Neostigmine Methyl Sulfate 1mg/mL Injection Syringes due to a lack of assurance of sterility. The product was distributed nationwide.

    Product
    NEOSTIGMINE METHYL SULFATE 1MG/ML INJ SOL SYR, 5 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0143-05
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Moxifloxacin Ophthalmic Solution Due to Sterility Concerns

    RXQ Compounding LLC is recalling Moxifloxacin 0.5% Ophthalmic Solution syringes because the product lacks assurance of sterility.

    Product
    MOXIFLOXACIN 0.5% OPHTH SOLUTION SYRINGE, 1 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0973-81
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Sodium Bicarbonate Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Sodium Bicarbonate 8.4% Injection due to a lack of assurance of sterility. The product is distributed nationwide.

    Product
    SODIUM BICARBONATE 8.4% (1 MEQ/ML) INJ SOLN (PFV), 50 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0957-50
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Pyridoxine Vials Due to Sterility Concerns

    RXQ Compounding LLC is recalling Pyridoxine (MDV) 100mg/mL vials because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    PYRIDOXINE (MDV) 100MG/ML, 30ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0956-30
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Lidocaine HCL 2% Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Lidocaine HCL 2% Injection Solution because the product lacks assurance of sterility. The recall covers all lots within their expiry dates.

    Product
    LIDOCAINE HCL 2% INJECTION SOLUTION (NPV), 20ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0172-20
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Turbo Caine 2.5 Due to Sterility Concerns

    RXQ Compounding LLC is recalling Turbo Caine 2.5 syringes because the FDA determined there is a lack of assurance of sterility.

    Product
    TURBO CAINE 2.5 (PHEN2.5/CYCLO1/ TROP1/TETRA 0.5), 0.4 ML per Syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0193-81
    Category
    Distribution
    0 states
  • HighFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Hydrogen Peroxide Injectable Due to Sterility Concerns

    RXQ Compounding LLC is recalling Hydrogen Peroxide 3% Injectable PFV because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    HYDROGEN PEROXIDE 3% INJECTABLE PFV, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0907-30
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2019-08-14

    RXQ Compounding Recalls Procaine HCL 8% Injectable Due to Sterility Concerns

    RXQ Compounding LLC is recalling Procaine HCL 8% Injectable due to a lack of assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    PROCAINE HCL 8% (PFV) INJECTABLE, 10ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0970-10
    Category
    Distribution
    0 states
RXQ Compounding LLC recalled 86 products on 2019-08-14 · The Recall Desk